Dr Reddys Laboratories intimates of completion of USFDA audit of Srikakulam Plant (SEZ) Unit I

Capital Market 

Receives one observation in Form 483

announced that the audit of its Formulations Srikakulam Plant (SEZ) Unit I, Andhra Pradesh, by the US FDA, has been completed on 16 June 2017. The Company has been issued a Form 483 with one observation.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dr Reddys Laboratories intimates of completion of USFDA audit of Srikakulam Plant (SEZ) Unit I

Receives one observation in Form 483

Receives one observation in Form 483

announced that the audit of its Formulations Srikakulam Plant (SEZ) Unit I, Andhra Pradesh, by the US FDA, has been completed on 16 June 2017. The Company has been issued a Form 483 with one observation.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22